169 related articles for article (PubMed ID: 10740264)
1. Developments and improvements in the manufacturing of human therapeutics with mammalian cell cultures.
Hesse F; Wagner R
Trends Biotechnol; 2000 Apr; 18(4):173-80. PubMed ID: 10740264
[TBL] [Abstract][Full Text] [Related]
2. The state of biopharmaceutical manufacturing.
Molowa DT; Mazanet R
Biotechnol Annu Rev; 2003; 9():285-302. PubMed ID: 14650933
[TBL] [Abstract][Full Text] [Related]
3. Building biomanufacturing capacity--the chapter and verse.
Kamarck ME
Nat Biotechnol; 2006 May; 24(5):503-5. PubMed ID: 16680126
[TBL] [Abstract][Full Text] [Related]
4. Validation of biopharmaceutical purification processes for virus clearance evaluation.
Darling A
Mol Biotechnol; 2002 May; 21(1):57-83. PubMed ID: 11989660
[TBL] [Abstract][Full Text] [Related]
5. Sustainability in the biopharmaceutical industry: Seeking a holistic perspective.
Lalor F; Fitzpatrick J; Sage C; Byrne E
Biotechnol Adv; 2019; 37(5):698-707. PubMed ID: 30922993
[TBL] [Abstract][Full Text] [Related]
6. Advancement in bioprocess technology: parallels between microbial natural products and cell culture biologics.
Bandyopadhyay AA; Khetan A; Malmberg LH; Zhou W; Hu WS
J Ind Microbiol Biotechnol; 2017 May; 44(4-5):785-797. PubMed ID: 28185098
[TBL] [Abstract][Full Text] [Related]
7. Trends in capacity utilization for therapeutic monoclonal antibody production.
Langer ES
MAbs; 2009; 1(2):151-6. PubMed ID: 20061821
[TBL] [Abstract][Full Text] [Related]
8. Mammalian cell culture for production of recombinant proteins: A review of the critical steps in their biomanufacturing.
O'Flaherty R; Bergin A; Flampouri E; Mota LM; Obaidi I; Quigley A; Xie Y; Butler M
Biotechnol Adv; 2020 Nov; 43():107552. PubMed ID: 32416132
[TBL] [Abstract][Full Text] [Related]
9. The use of 'Omics technology to rationally improve industrial mammalian cell line performance.
Lewis AM; Abu-Absi NR; Borys MC; Li ZJ
Biotechnol Bioeng; 2016 Jan; 113(1):26-38. PubMed ID: 26059229
[TBL] [Abstract][Full Text] [Related]
10. Current state-of-the-art in plant-based antibody production systems.
Donini M; Marusic C
Biotechnol Lett; 2019 Mar; 41(3):335-346. PubMed ID: 30684155
[TBL] [Abstract][Full Text] [Related]
11. High-throughput process development for biopharmaceutical drug substances.
Bhambure R; Kumar K; Rathore AS
Trends Biotechnol; 2011 Mar; 29(3):127-35. PubMed ID: 21255855
[TBL] [Abstract][Full Text] [Related]
12. Mammalian cell culture capacity for biopharmaceutical manufacturing.
Ecker DM; Ransohoff TC
Adv Biochem Eng Biotechnol; 2014; 139():185-225. PubMed ID: 23748352
[TBL] [Abstract][Full Text] [Related]
13. Development toward rapid and efficient screening for high performance hydrolysate lots in a recombinant monoclonal antibody manufacturing process.
Luo Y; Pierce KM
Biotechnol Prog; 2012 Jul; 28(4):1061-8. PubMed ID: 22641483
[TBL] [Abstract][Full Text] [Related]
14. Industrialization of mAb production technology: the bioprocessing industry at a crossroads.
Kelley B
MAbs; 2009; 1(5):443-52. PubMed ID: 20065641
[TBL] [Abstract][Full Text] [Related]
15. Process analytical technology (PAT) for biopharmaceutical products: Part I. concepts and applications.
Read EK; Park JT; Shah RB; Riley BS; Brorson KA; Rathore AS
Biotechnol Bioeng; 2010 Feb; 105(2):276-84. PubMed ID: 19731252
[TBL] [Abstract][Full Text] [Related]
16. Process technology for production and recovery of heterologous proteins with Pichia pastoris.
Jahic M; Veide A; Charoenrat T; Teeri T; Enfors SO
Biotechnol Prog; 2006; 22(6):1465-73. PubMed ID: 17137292
[TBL] [Abstract][Full Text] [Related]
17. A novel chemically defined medium for the biotechnological and biomedical exploitation of the cell factory Leishmania tarentolae.
Cattaneo GM; Varotto-Boccazzi I; Molteni R; Ronchetti F; Gabrieli P; Mendoza-Roldan JA; Otranto D; Montomoli E; Bandi C; Epis S
Sci Rep; 2024 Apr; 14(1):9562. PubMed ID: 38671070
[TBL] [Abstract][Full Text] [Related]
18. Applications of Raman Spectroscopy in Biopharmaceutical Manufacturing: A Short Review.
Buckley K; Ryder AG
Appl Spectrosc; 2017 Jun; 71(6):1085-1116. PubMed ID: 28534676
[TBL] [Abstract][Full Text] [Related]
19. 2011 in reflection.
Mullard A
Nat Rev Drug Discov; 2012 Jan; 11(1):6-8. PubMed ID: 22212664
[No Abstract] [Full Text] [Related]
20. Innovative and economic potential of mammalian cell culture.
Werner RG
Arzneimittelforschung; 1998 Apr; 48(4):423-6. PubMed ID: 9608886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
